Lung-Specific mRNA Delivery Enabled by Sulfonium Lipid Nanoparticles
Nano Letters · 03.07.2024 · 24 (26) · 8080-8088
DOI: 10.1021/acs.nanolett.4c01854 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, online erschienen am 18.06.2024. Verfasst von David O Popoola und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, State University of New York, Upstate Medical University, Syracuse, New York 13210, United States. Hauptthemen laut MEDLINE: Lung, Nanoparticles, RNA, Messenger, Lipids. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, State University of New York Upstate Medical University, National Institutes of Health.
Abstract (Originalsprache)
Among various mRNA carrier systems, lipid nanoparticles (LNPs) stand out as the most clinically advanced. While current clinical trials of mRNA/LNP therapeutics mainly address liver diseases, the potential of mRNA therapy extends far beyond─yet to be unraveled. To fully unlock the promises of mRNA therapy, there is an urgent need to develop safe and effective LNP systems that can target extrahepatic organs. Here, we report on the development of sulfonium lipid nanoparticles (sLNPs) for systemic mRNA delivery to the lungs. sLNP effectively and specifically delivered mRNA to the lungs following intravenous administration in mice. No evidence of lung and systemic inflammation or toxicity in major organs was induced by sLNP. Our findings demonstrated that the newly developed lung-specific sLNP platform is both safe and efficacious. It holds great promise for advancing the development of new mRNA-based therapies for the treatment of lung-associated diseases and conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, State University of New York, Upstate Medical University, Syracuse, New York 13210, United States.
- Department of Neuroscience and Physiology, State University of New York, Upstate Medical University, Syracuse, New York 13210, United States.
- Department of Biochemistry and Molecular Biology, State University of New York, Upstate Medical University, Syracuse, New York 13210, United States.
- Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia 30322, United States.
- Department of Surgery, State University of New York, Upstate Medical University, Syracuse, New York 13210, United States.
ORCID-Profile: Juntao Luo, Yamin Li
Förderung
- NIBIB NIH HHS
- State University of New York Upstate Medical University
- National Institutes of Health
Zitieren
APA
Popoola, D. O., Cao, Z., Men, Y., Li, X., Viapiano, M., Wilkens, S., Luo, J., Teng, Y., Meng, Q., & Li, Y. (2024). Lung-Specific mRNA Delivery Enabled by Sulfonium Lipid Nanoparticles. Nano Letters, 24(26), 8080-8088. https://doi.org/10.1021/acs.nanolett.4c01854
Vancouver
Popoola DO, Cao Z, Men Y, Li X, Viapiano M, Wilkens S, et al. Lung-Specific mRNA Delivery Enabled by Sulfonium Lipid Nanoparticles. Nano Letters. 2024;24(26):8080-8088. doi:10.1021/acs.nanolett.4c01854
BibTeX
@article{Popoola2024,
author = {Popoola, David O and Cao, Zhi and Men, Yuqin and Li, Xinyuan and Viapiano, Mariano and Wilkens, Stephan and Luo, Juntao and Teng, Yong and Meng, Qinghe and Li, Yamin},
title = {Lung-Specific mRNA Delivery Enabled by Sulfonium Lipid Nanoparticles},
journal = {Nano Letters},
year = {2024},
volume = {24},
number = {26},
pages = {8080--8088},
doi = {10.1021/acs.nanolett.4c01854}
}
EUVIMED